Literature DB >> 29761360

Tumour volume of resectable oesophageal squamous cell carcinoma measured with MRI correlates well with T category and lymphatic metastasis.

Lan Wu1, Jing Ou1, Tian-Wu Chen2, Rui Li1, Xiao-Ming Zhang1, Yan-Li Chen1, Yu Jiang1, Jian-Qiong Yang1, Jin-Ming Cao1.   

Abstract

OBJECTIVES: To determine association of gross tumour volume (GTV) of resectable oesophageal squamous cell carcinoma (SCC) measured on T2-weighted imaging (T2WI), contrast-enhanced T1-weighted imaging (CE-T1WI) and diffusion-weighted imaging (DWI) with T category and lymphatic metastasis (LM).
METHODS: Sixty oesophageal SCC patients underwent fat-suppressed T2WI, CE-T1WI and DWI with b values of 0, 500 and 800 s/mm2. GTV was measured on three sequences. Statistical analyses were performed to determine association of GTV with T category and LM.
RESULTS: Spearman's rank correlation analysis showed positive association of GTV with T category and LM (all p values < 0.01). Differences in GTV were found between T1 and T2 or T3 categories shown by Kruskal-Wallis H and one-way ANOVA tests, and between T1/T2 and T3 and between tumours with and without LM by Mann-Whitney U tests (all p values < 0.05). Receiver operating characteristic analyses showed cut-off GTVs of 5.795, 5.276 and 10.11 cm3 on CE-T1WI could better differentiate T1 from T2 categories, T1 from T3, and T1-2 from T3 than those of 7.066, 7.045 and 8.504 cm3 on T2WI, of 5.793, 6.609 and 6.989 cm3 on DWI with b value of 500 s/mm2, and of 4.156, 4.519 and 4.985 cm3 with b value of 800 s/mm2, respectively. Cut-off of 10.462 cm3 on DWI with b value of 500 s/mm2 could better identify LM than of 12.38, 8.793 and 9.600 cm3 on T2WI, CE-T1WI and DWI with b value of 800 s/mm2, respectively.
CONCLUSIONS: GTVs on T2WI, CE-T1WI and DWI are associated with T category of and LM of oesophageal SCC. KEY POINTS: • GTV is associated with T category and lymphatic metastasis of oesophageal SCC • GTV measured on contrast-enhanced T 1 -weighted imaging better identifies T category • GTV measured on DWI with b value of 500 s/mm 2 better identifies lymphatic metastasis.

Entities:  

Keywords:  Diffusion-weighted imaging; Lymphatic metastasis; Magnetic resonance imaging; Oesophagus; Squamous cell carcinoma

Mesh:

Year:  2018        PMID: 29761360     DOI: 10.1007/s00330-018-5477-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.

Authors:  Christopher P Twine; S Ashley Roberts; Wyn G Lewis; B Vicki Dave; Claire E Rawlinson; David Chan; Mark Robinson; Tom D Crosby
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

2.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

3.  Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone.

Authors:  Erik Rud; Dagmar Klotz; Kristin Rennesund; Eduard Baco; Viktor Berge; Diep Lien; Aud Svindland; Eskild Lundeby; Rolf E Berg; Lars M Eri; Heidi B Eggesbø
Journal:  BJU Int       Date:  2014-12       Impact factor: 5.588

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.

Authors:  Hang Li; Tian-wu Chen; Zhen-lin Li; Xiao-ming Zhang; Xiao-li Chen; Li-ying Wang; Li Zhou; Rui Li; Chun-ping Li; Xiao-hua Huang
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

6.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer.

Authors:  Aine Sakurada; Taro Takahara; Thomas C Kwee; Tomohiro Yamashita; Seiji Nasu; Tomohiko Horie; Marc Van Cauteren; Yutaka Imai
Journal:  Eur Radiol       Date:  2009-01-27       Impact factor: 5.315

7.  Computed tomography scan as a tool to predict tumor T category in resectable esophageal squamous cell carcinoma.

Authors:  Hang Li; Tian-Wu Chen; Xiao-Ming Zhang; Zhen-Lin Li; Xiao-Li Chen; Hong-Jie Tang; Xiao-Hua Huang; Nan Chen; Qi Yang; Jiani Hu
Journal:  Ann Thorac Surg       Date:  2013-03-15       Impact factor: 4.330

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Value of percent change in tumoral volume measured at T2 -weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.

Authors:  Emilio Quaia; Antonio Giulio Gennari; Maria Chiara Ricciardi; Veronica Ulcigrai; Roberta Angileri; Maria Assunta Cova
Journal:  J Magn Reson Imaging       Date:  2016-05-24       Impact factor: 4.813

10.  Submucosal Invasive Depth Predicts Lymph Node Metastasis and Poor Prognosis in Submucosal Invasive Esophageal Squamous Cell Carcinoma.

Authors:  Tomohiro Kadota; Tomonori Yano; Takeo Fujita; Hiroyuki Daiko; Satoshi Fujii
Journal:  Am J Clin Pathol       Date:  2017-11-02       Impact factor: 2.493

View more
  2 in total

1.  Tumor Stage-Based Gross Tumor Volume of Resectable Esophageal Squamous Cell Carcinoma Measured on CT: Association With Early Recurrence After Esophagectomy.

Authors:  Yu-Ping Wu; Sun Tang; Bang-Guo Tan; Li-Qin Yang; Fu-Lin Lu; Tian-Wu Chen; Jing Ou; Xiao-Ming Zhang; Dan Gao; Ke-Ying Li; Zi-Yi Yu; Zhao Tang
Journal:  Front Oncol       Date:  2021-10-22       Impact factor: 6.244

Review 2.  The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer.

Authors:  Anna Pellat; Anthony Dohan; Philippe Soyer; Julie Veziant; Romain Coriat; Maximilien Barret
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.